Ronaghi A, Stan T, Barrientos S, Halje P, Nasretdinov A, Censoni L
Eur J Neurosci. 2025; 61(5):e70032.
PMID: 40042199
PMC: 11881547.
DOI: 10.1111/ejn.70032.
Prates-Rodrigues M, Schweizer B, de Paula Gomes C, Ribeiro A, Padovan-Neto F, Masini D
J Neurochem. 2025; 169(2):e70008.
PMID: 39901598
PMC: 11791392.
DOI: 10.1111/jnc.70008.
Kim N, Goto Y, Lee Y
Pharmacol Rep. 2024; 77(1):247-259.
PMID: 39466340
DOI: 10.1007/s43440-024-00673-7.
Prudon N, Cordero-Espinoza L, Abarkan M, Gurchenkov B, Morel C, Lepleux M
Neurotherapeutics. 2024; 21(5):e00436.
PMID: 39353832
PMC: 11581877.
DOI: 10.1016/j.neurot.2024.e00436.
Stanley O, Swaminathan A, Wojahn E, Bao C, Ahmed Z, Cullen K
Sci Rep. 2024; 14(1):20914.
PMID: 39245735
PMC: 11381541.
DOI: 10.1038/s41598-024-71665-z.
The 6-OHDA Parkinson's Disease Mouse Model Shows Deficits in Sensory Behavior.
Linen S, Chang N, Hess E, Stanley G, Waiblinger C
bioRxiv. 2024; .
PMID: 38895263
PMC: 11185599.
DOI: 10.1101/2024.06.05.597339.
Neurotransmitter accumulation and Parkinson's disease-like phenotype caused by anion channelrhodopsin opto-controlled astrocytic mitochondrial depolarization in substantia nigra pars compacta.
Li S, Wang D, Liu D, Meng X, Wang Z, Guo X
MedComm (2020). 2024; 5(6):e568.
PMID: 38756440
PMC: 11094672.
DOI: 10.1002/mco2.568.
Dopamine lesions alter the striatal encoding of single-limb gait.
Yang L, Singla D, Wu A, Cross K, Masmanidis S
Elife. 2024; 12.
PMID: 38526916
PMC: 10963031.
DOI: 10.7554/eLife.92821.
Establishment of a 6-OHDA Induced Unilaterally Lesioned Male Wistar Rat Model of Parkinson's Disease.
Kumari N, Luthra P
Methods Mol Biol. 2024; 2761:491-498.
PMID: 38427257
DOI: 10.1007/978-1-0716-3662-6_33.
Exploring the Central Mechanisms of Botulinum Toxin in Parkinson's Disease: A Systematic Review from Animal Models to Human Evidence.
Cutrona C, Marchet F, Costanzo M, De Bartolo M, Leodori G, Ferrazzano G
Toxins (Basel). 2024; 16(1).
PMID: 38251226
PMC: 10818853.
DOI: 10.3390/toxins16010009.
Quantifying changes in local basal ganglia structural connectivity in the 6-hydroxydopamine model of Parkinson's Disease using correlational tractography.
Moshchin M, Cheng K, Osting S, Laluzerne M, Hurley S, Singh A
Int IEEE EMBS Conf Neural Eng. 2023; 2023.
PMID: 37680669
PMC: 10484213.
DOI: 10.1109/ner52421.2023.10123839.
The Role of a Dopamine-Dependent Limbic-Motor Network in Sensory Motor Processing in Parkinson Disease.
Mann L, Servant M, Hay K, Song A, Trujillo P, Yan B
J Cogn Neurosci. 2023; 35(11):1806-1822.
PMID: 37677065
PMC: 10594953.
DOI: 10.1162/jocn_a_02048.
Reversal of pathological motor behavior in a model of Parkinson's disease by striatal dopamine uncaging.
Zamora-Ursulo M, Perez-Becerra J, Tellez L, Saderi N, Carrillo-Reid L
PLoS One. 2023; 18(8):e0290317.
PMID: 37594935
PMC: 10437883.
DOI: 10.1371/journal.pone.0290317.
The Therapeutic Frequency Profile of Subthalamic Nucleus Deep Brain Stimulation in Rats Is Shaped by Antidromic Spike Failure.
Cassar I, Grill W
J Neurosci. 2023; 43(27):5114-5127.
PMID: 37328290
PMC: 10324992.
DOI: 10.1523/JNEUROSCI.1798-22.2023.
Recent advances in treatment of spatial neglect: networks and neuropsychology.
Carter A, Barrett A
Expert Rev Neurother. 2023; 23(7):587-601.
PMID: 37273197
PMC: 10740348.
DOI: 10.1080/14737175.2023.2221788.
Deconvolution of spatial sequencing provides accurate characterization of hESC-derived DA transplants .
Rajova J, Davidsson M, Avallone M, Hartnor M, Aldrin-Kirk P, Cardoso T
Mol Ther Methods Clin Dev. 2023; 29:381-394.
PMID: 37251982
PMC: 10209706.
DOI: 10.1016/j.omtm.2023.04.008.
A Combined α-Synuclein/Fibril (SynFib) Model of Parkinson-Like Synucleinopathy Targeting the Nigrostriatal Dopamine System.
Bjorklund A, Nilsson F, Mattsson B, Hoban D, Parmar M
J Parkinsons Dis. 2022; 12(8):2307-2320.
PMID: 36189605
PMC: 9837691.
DOI: 10.3233/JPD-223452.
Lateralization in hemi-parkinsonian rats is affected by deep brain stimulation or glutamatergic neurotransmission in the inferior colliculus.
Melo-Thomas L, Tacken L, Richter N, Almeida D, Raposo C, de Melo S
eNeuro. 2022; .
PMID: 35817565
PMC: 9337613.
DOI: 10.1523/ENEURO.0076-22.2022.
Neuroinflammation in Parkinson's Disease - Putative Pathomechanisms and Targets for Disease-Modification.
Grotemeyer A, McFleder R, Wu J, Wischhusen J, Ip C
Front Immunol. 2022; 13:878771.
PMID: 35663989
PMC: 9158130.
DOI: 10.3389/fimmu.2022.878771.
Modulation by Estradiol of L-Dopa-Induced Dyskinesia in a Rat Model of Post-Menopausal Hemiparkinsonism.
Kolmancic K, Zivin M, Zorovic M
Life (Basel). 2022; 12(5).
PMID: 35629308
PMC: 9143229.
DOI: 10.3390/life12050640.
